ML120180131

From kanterella
Jump to navigation Jump to search

Dow Chemical Company - Letter to Licensee Determination of Acceptability
ML120180131
Person / Time
Site: Dow Chemical Company
Issue date: 01/26/2012
From: Geoffrey Wertz
Research and Test Reactors Licensing Branch
To: O'Connor P
Dow Chemical Co
Wertz G, NRR/DPR/PRLB, 301-415-0893
Shared Package
ML120180128 List:
References
TAC ME1595
Download: ML120180131 (3)


Text

January 26, 2012 Dr. Paul J. OConnor, Ph.D.

Facility Director Dow Chemical TRIGA Research Reactor Dow Chemical Company Building 1602 Midland, MI 48674

SUBJECT:

DOW CHEMICAL COMPANY - DETERMINATION OF ACCEPTABILITY AND SUFFICIENCY FOR DOCKETING AND OPPORTUNITY TO PROVIDE WRITTEN COMMENTS AND/OR REQUEST A HEARING AND ORDER IMPOSING PROCEDURES FOR ACCESS TO SENSITIVE UNCLASSIFIED NON-SAFEGUARDS INFORMATION FOR THE RENEWAL OF FACILITY LICENSE NO. R-108 FOR THE DOW CHEMICAL TRIGA RESEARCH REACTOR (TAC NO. ME1595)

Dear Dr. OConnor:

By letter dated April 1, 2009, as supplemented by letters dated August 11, September 24, 2010, January 12, February 11, April 11, August 12, August 31, October 12, November 10, and December 6, 2011, the DOW Chemical Company submitted an application to the U.S. Nuclear Regulatory Commission (NRC) for renewal of Facility License No. R-108 for the DOW Chemical TRIGA Research Reactor (DTRR).

Based on review of the application, the NRC staff has determined that the DOW Chemical Company has submitted sufficient information such that the application is acceptable for docketing in accordance with Title 10 of the Code of Federal Regulations, Section 50.33 and Section 50.34. However, this determination does not preclude requests for additional information as the review proceeds. The Notice of Acceptability for Docketing has been forwarded to the Office of the Federal Register for publication.

If you have any questions regarding this matter, please contact Mr. Geoffrey Wertz at 301-415-0893 or via email at Geoffrey.wertz@nrc.gov.

Sincerely,

/RA/

Geoffrey A. Wertz, Project Manager Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No. 50-264 cc: See next page

Dow Chemical Company Docket No. 50-264 cc:

Office of the Mayor 333 West Ellsworth Midland, MI 48640 Office of the Governor Room 1 - Capitol Building Lansing, MI 48913 Mr. Dan Rader Environmental Health and Safety Responsible Care Leader Chair, Radiation Safety Committee 1790 Building Midland, MI 48674 Dr. Wayde Konze Global Research and Development Director for Analytical Sciences Chair, Reactor Operations Committee The Dow Chemical Company 1897 Building Midland, MI 48667 Test, Research, and Training Reactor Newsletter University of Florida 202 Nuclear Sciences Center Gainesville, FL 32611

Pkg: ML120180128; Ltr: ML120180131 Memo: ML120180139 FRN:

ML120180152 *Concurrence via email Template # ADM-012